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Summary
Understanding the regulation of immune responses
is central for control of autoimmune and infectious
disease. In murine models of autoimmunity and
chronic inflammatory disease, potent regulatory T
lymphocytes have recently been characterized. De-
spite an explosion of interest in these cells, their rele-
vance to human disease has been uncertain. In a lon-
gitudinal study of malaria sporozoite infection via the
natural route, we provide evidence that regulatory T
cells have modifying effects on blood-stage infection
in vivo in humans. Cells with the characteristics of*Correspondence: eleanor.riley@lshtm.ac.uk
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7 Present address: MRC Laboratories, PO Box 273, Fajara, The
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ease Control, 1600 Clifton Road, N.E. Atlanta, Georgia 30333.
9 Present address: Department of Dermatology, University of Frei-
burg, Hauptstrasse 7, DE-79104, Freiburg, Germany.regulatory T cells are rapidly induced following
blood-stage infection and are associated with a burst
of TGF- production, decreased proinflammatory cy-
tokine production, and decreased antigen-specific
immune responses. Both the production of TGF-
and the presence of CD4+CD25+FOXP3+ regulatory T
cells are associated with higher rates of parasite
growth in vivo. P. falciparum-mediated induction of
regulatory T cells may represent a parasite-specific
virulence factor.
Introduction
Initially characterized by their ability to control autoim-
mune disease in mice (Sakaguchi et al., 1995), regula-
tory T cells have now been shown, in model systems,
to influence immune responses to a range of microbial
infections (Rouse and Suvas, 2004). Among several
forms of antigen-specific T cells with regulatory proper-
ties (Barrat et al., 2002; Chen et al., 1994; Groux et al.,
1997), a population of CD4+ T cells that express CD25
(IL-2Rα) in the resting state has been described in mice
(Sakaguchi et al., 1995) and humans (Dieckmann et al.,
2001; Jonuleit et al., 2001; Levings et al., 2001; Ste-
phens et al., 2001; Taams et al., 2001). These cells spe-
cifically express the X-linked forkhead/winged helix
transcription factor FOXP3 (foxp3 in mice) (Brunkow et
al., 2001; Schubert et al., 2001), which has been associ-
ated with their development and function in both mice
and humans (Fontenot et al., 2003; Hori et al., 2003;
Khattri et al., 2003; Yagi et al., 2004). Some CD4+CD25+
regulatory T cells are thymus derived and are now des-
ignated “endogenous T reg” or “natural T reg,” but
there is increasing evidence in mice and humans that
CD4+CD25+FOXP3-expressing T cells may be very rap-
idly induced in the periphery (Chen et al., 2003; Fantini
et al., 2004; Park et al., 2004; Schramm et al., 2004;
Zheng et al., 2004). Whatever their origin, T reg appear
to mediate their effects either by direct cell contact
(Thornton and Shevach, 2000) or by induction of the
immunoregulatory cytokines IL-10 or TGF-β (Powrie et
al., 2003). In experimental situations, such as Leish-
mania major infection of resistant mouse strains (Bel-
kaid et al., 2002) or Herpes simplex virus infection of
the murine cornea (Suvas et al., 2004), interactions be-
tween pathogens and T reg have been shown to be of
mutual benefit to pathogen and host, allowing infection
to persist, thereby maintaining long-term memory and
resistance to reinfection (Belkaid et al., 2002), while
minimizing T cell-mediated immunopathology (Suvas et
al., 2004). However, disrupting the balance of T reg to
T effector cells can lead to disease reactivation (Men-
dez et al., 2004). Whether T reg play a similar role in
natural host-parasite interactions is currently unknown,
as is their potential role in modulating the human im-
mune response to infection.
Malaria infection is characterized, following emer-
gence of parasites from the liver, by an early phase of
logarithmic parasite replication in circulating red blood
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288cells, which is eventually brought under control by im-
mune effectors; this is typically followed by low-grade,
subclinical parasite persistence. In murine malaria, reg-
ulation of Th-1 effectors by IL-10 (Li et al., 2003) and
TGF-β (Omer and Riley, 1998) is essential for limiting
immunopathology, but induction (or administration) of
TGF-β during early, acute blood-stage infection sup-
presses protective proinflammatory cytokine responses,
leading to unrestrained parasite proliferation and in-
creased disease severity (Omer et al., 2003b; Tsutsui
and Kamiyama, 1999). In a malaria model where dis-
ease is exacerbated by early TGF-β production, neu-
tralization of IL-10 and TGF-β signaling (Omer et al.,
2003b), or depletion of CD25+ cells (Hisaeda et al.,
2004), restores an early Th-1 response, retards early
parasite replication, and allows the infection to be re-
solved.
Unraveling the role of T reg in human infection is
hampered by difficulties of following individual patients
from the uninfected state to acute infection and subse-
quently to either chronic infection or cure. We have
therefore exploited the opportunity for studying the nat-
ural history of human Plasmodium falciparum infection
following experimental sporozoite infection of human
volunteers via infectious mosquito bites within the con-
text of phase IIa clinical trials to evaluate the efficacy
of preerythrocytic stage malaria vaccines (McConkey
et al., 2003).
Results
We first assessed parasite density (detection of P. falci-
parum DNA by quantitative PCR) and circulating cyto-
kine concentrations in 14 vaccinated (but not pro-
tected) individuals and 12 unvaccinated individuals
over a period of 35 days, following live P. falciparum
sporozoite infection. Serum and platelet-depleted
plasma collected prior to sporozoite infection (day 0), 4
days after infection, and every 12 hr from 6 days postin-
fection until the first microscopic detection of parasi-
taemia (at which point subjects were treated with a full
curative dose of artemether with lumefantrine) were
tested by multiplex cytokine bead array and (for latent
and bioactive TGF-β) by ELISA. Blood samples col-
lected every 12 hr over a period of 4 days from 2 unvac-
cinated, uninfected subjects provided control data for
physiological variation in plasma cytokine concentra-
tions. Data from the vaccinated and unvaccinated
groups were pooled, as the vaccination regime em-
ployed had no detectable protective effect and there
was no consistent or significant difference in values for
any of the parameters measured between the two
groups; this can be further justified on the basis that
any vaccine-induced immune response would be spe-
cific for preerythrocytic antigens and would be ex-
pected to have no effect on subsequent blood-stage in-
fection.
Baseline TGF-β concentrations for each individual
were calculated as the mean of the day 0 and day 4
values (i.e., prior to emergence of parasites from the
liver) and were no different from those observed in un-
vaccinated, unchallenged controls (mean latent TGF-β:
measured in nonvaccinated sporozoite infected = 8,129
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bg/ml [CI 95% 3,593–12,665], n = 12; and uninfected
ontrols = 6,787 pg/ml [CI 95% 5,293–8,280], n = 16
easurements; p = 0.5. Mean bioactive TGF-β: mea-
ured in all sporozoite infected = 23.1 pg/ml [CI 95%
8.5–27.5], n = 26; uninfected controls = 19.5 pg/ml [CI
5% 16.4–22.5], n = 16; p = 0.24).
GF- Induction on Parasite Emergence
rom the Liver
n 8 of the 12 unvaccinated subjects and in 5 of the 14
accinated (but not protected) subjects, a marked peak
f circulating, bioactive TGF-β was observed in plasma
ollected within ±12 hr of the first detection of circulat-
ng P. falciparum DNA, which occurred on average 7.6
ays (CI 95% 7.3–8) after sporozoite-initiated infection
data for 5 individuals are shown in Figure 1A). In these
3 subjects, TGF-β peak concentrations were on average
.2-fold (CI 95% 5.3–13.2) higher than their individual
aseline TGF-β concentrations, in contrast to the 1.8-
old (CI 95% 1.2–2.4) increase observed in 13 subjects
ithout a TGF-β peak (Figure 1B). Mean maximum TGF-β
oncentrations for subjects with and without a TGF-β peak
re shown in Table 1. Taking the whole cohort together
n = 26), the median maximum concentrations of bioac-
ive TGF-β within 12 hr of parasite emergence from the
iver were significantly higher than at baseline (p =
.0001, Figure 1C).
Latent TGF-β concentrations, assessed in samples
rom unvaccinated, sporozoite-infected subjects, mir-
ored concentrations of bioactive TGF-β but were
100-fold higher (Table 1); the peak of spontaneously
ioactive TGF-β coincided with, or was preceded by, a
eak in latent TGF-β. In 17/26 (65%) subjects, including
ome subjects who did not show a distinct cytokine
eak at the time of parasite emergence from the liver,
GF-β levels began to fluctuate from approximately day
onward and remained slightly above baseline until
arasitaemia became patent by microscopy and the
ubjects were treated (Figures 1A and 1B).
These observations are consistent with release of
atent, biologically inactive TGF-β from intracellular
tores and its rapid conversion to the bioactive form
ither by endogenous activators or by components of
. falciparum schizonts (Omer et al., 2003a) at the time
f emergence of merozoites from hepatic schizonts; the
ubsequent TGF-β peak at 9–10 days may be associ-
ted with the first wave of erythrocytic schizogony.
educed Proinflammatory Response and Enhanced
arasite Growth in Presence of TGF-
e compared proinflammatory cytokine responses and
arasite growth rates between the 13 individuals who
ade an early TGF-β peak and the 13 individuals who
id not. Although initial parasite growth rates were not
ifferent between the two groups, from day 8.5 onward
arasitaemia rose significantly faster in individuals who
ade an early plasma TGF-β response than in those
ho did not (p = 0.008; Figure 2).
Although similar proportions of subjects in the TGF-
-positive group (10/13; 77%) and in the TGF-β-nega-
ive group 9/13 (69%) showed a 2-fold or more increase
n serum IFN-γ concentration above their individual
aseline, upregulation of IFN-γ occurred almost a day
Regulatory T Cells in Human Malaria
289Figure 1. Circulating Cytokine Concentrations at Time of Parasite Emergence from the Liver
(A and B) The kinetics of spontaneously bioactive TGF-β in plasma after sporozoite challenge are shown for (A) 5 subjects who showed a
transient increase in TGF-β within ±12 hr of the first detection of circulating P. falciparum DNA, and (B) 5 individuals who did not show a TGF-β peak.
(C) TGF-β level at baseline (mean TGF-β concentration on days 0 and 4) is compared to maximum TGF-β concentration within ±12 hr of first
detection of parasite DNA.
(D) Comparison of TGF-β (dotted line) and IFN-γ (continuous line) kinetics in subjects with (upper graph) and without (lower graph) initial TGF-β peak.TGF-β-positive subjects was almost three times lower
Table 1. Circulating Concentrations of TGF-β and IFN-γ in Subjects with and without a Peak of TGF-β Production at the Time of Parasite Emergence
from the Liver
With TGF-β Peak Without TGF-β Peak p
All TGF-β+
versus All
Unvaccinated Vaccinated All Unvaccinated Vaccinated All TGF-β−
Number of subjects 8 5 13 4 9 13
Max. bioactive TGF-β at 191 (95–287) 203 (34–371) 196 (125–267) 74 (23–124) 26 (18–34) 41 (22–58)
parasite emergence (mean
pg/ml [95% CI])
Max. fold increase in 8.3 (3.0–13.5) 10.7 (1.5–20) 9.2 (5.3–13.2) 2.8 (1.1–4.5) 1.4 (1.0–1.8) 1.8 (1.2–2.4)
bioactive TGF-β at parasite
emergence (mean [95% CI])
Max. latent TGF-β level at 18,427 (10,778– not 8,497 (4,667– not
parasite emergence 31,507) determined 15,471) determined
(geometric mean pg/ml
[95% CI])
Fold increase in latent TGF-β 4.76 (1.1–8.4) not 1.79 (0.5–3.1) not
at parasite emergence determined determined
(mean [95% CI])
IFN-γ peak response 15.8 (4.3–59) 74.7 (38.5– 26.55 (38.5– 96.2 (18.5–499) 71.7 (37–139) 78.5 (46–134) 0.035
(geometric mean pg/ml 144.9) 68.2)
[95% CI])
1D). Furthermore, levels of IL-6 and IL-12, determinedlater in the TGF-β-positive group than in the TGF-β-
negative group (mean 10.5 dpi versus 9.6 dpi, respec-
tively). Furthermore, the peak IFN-γ concentration inthan in those subjects without raised TGF-β levels (Ta-
ble 1; p = 0.035), and in some TGF-β-positive subjects,
no upregulation of IFN-γ was observed at all (Figure
Immunity
290Figure 2. Accelerated Parasite Growth in Presence of TGF-β
Geometric mean parasite density following sporozoite challenge in
subjects with a TGF-β peak at parasite emergence from the liver
(continuous line, n = 13) and subjects without a TGF-β peak (dotted
line, n = 13). From day 8.5, parasites grow significantly faster in
subjects with TGF-β peak as compared to subjects without TGF-β
peak (slope coefficient = 1.2, p = 0.008)
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sin unvaccinated subjects only, were 2.5 and 2 times
lower, respectively, in TGF-β-positive subjects than in
TGF-β-negative subjects, were detected in a lower pro-
portion of subjects, and occurred a day (IL-6) or 2.5
days (IL-12) later (data not shown). These observations
suggest that TGF-β may facilitate initial blood-stage
parasite growth by suppressing proinflammatory re-
sponses.
It is not yet clear why cytokine responses differ
among individuals. We consider it very unlikely that this
is due to differences between individuals in the size of
the sporozoite inoculum, as the estimated parasite bur-
dens in the liver, calculated as described (Bejon et al.,
2005), were very similar (p = 0.99) in the two groups.
Monocytes Are the Major Source of Early TGF-
To investigate the potential cellular source of TGF-β,
PBMCs collected on days 4 and 7 after sporozoite in-
fection from three subjects who had a peak of plasma
TGF-β on day 7 and from three subjects without a
TGF-β peak were stained ex vivo, without restimulation,
for intracellular latent TGF-β and expression of CD4,
CD8, or CD14 (Figure 3). In all subjects, irrespective of
their TGF-β status, the proportion of CD4+ cells de-
clined and the percentage of CD14+ cells increased
from day 4 to day 7 (CD4+: median day 4 = 50.2%, day
7 = 37.9%, p = 0.028; CD14+: median day 4 = 0.98%,
day 7 = 5.9%, p = 0.028). Subjects with a plasma TGF-β
peak were found to have increased proportions of
TGF-β-positive cells on day 7 (median 7.64% of all via-
ble PBMC), as compared to subjects without a TGF-β
peak (median 4.74%). As depicted in Figure 3D, the in-
creased proportion of TGF-β-positive cells was due to
an increase in the percentage of CD14+ TGF-β+ cells
(the median percentage of CD14+ cells that were TGF-β
positive increased from 73% to 90% in subjects with a
TGF-β plasma peak but declined from 83% to 58% in
subjects without a TGF-β peak). Very few CD4+ or CD8+
cells were TGF-β positive, but a population of TGF-β+
cells that were neither monocytes nor T cells was seen
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tn all donors (Figure 3D); these cells may be NK cells or
cells. In conclusion, the raised levels of TGF-β ob-
erved in some subjects at the time of parasite emer-
ence from the liver appears to be due to increased
ubers of CD14+ cells and a higher proportion of these
ells making TGF-β.
GF- Concentration Correlates
ith Upregulation of T reg
he observation that short-term culture of naive CD4+
D25− T cells with antigen in the presence of TGF-β
nduces expression of FOXP3 and their development
nto cells with the phenotypic and functional properties
f T reg (Chen et al., 2003; Fantini et al., 2004; Park
t al., 2004; Schramm et al., 2004; Zheng et al., 2004)
rompted us to compare FOXP3 expression in periph-
ral blood mononuclear cells from unvaccinated, ma-
aria-infected subjects over time. FOXP3 mRNA was
uantified by real-time PCR in 10 unvaccinated, sporo-
oite-infected individuals.
As shown in Figure 4A, FOXP3 expression increased
ignificantly between day 7 and day 10 pi (p = 0.008)
nd remained significantly elevated until at least day 35
i (p = 0.021), and, even in this small data set, the fold
ncrease in FOXP3 from days 7 to 10 was significantly
nd positively correlated with the fold increase in bio-
ctive TGF-β (TGF-β level at first detection of P. falci-
arum DNA compared to TGF-β level at baseline; r =
.653, p = 0.041) (Figure 4B).
To determine whether FOXP3 expression coincides
ith the expansion of a regulatory T cell population, the
roportion of T cells expressing the phenotypic charac-
eristics of T reg was determined by flow cytometry in
0 malaria-infected subjects. As suppressive function
egregates with the minor subset of CD4 cells exhibit-
ng the CD25hi phenotype (Baecher-Allan et al., 2001,
005), gates were set to include only the 2%–3% of
D4 cells expressing the highest levels of CD25. Fur-
hermore, as CD69 is upregulated on activated effector
cells but not on T reg (Park et al., 2004), we defined
regs as being CD3+CD4+CD25hiCD69− lymphocytes
Figures 4C–4E). Consistent with the upregulation in
OXP3 expression, the proportion of CD25hiCD69− cells
mong CD4+CD3+ lymphocytes increased significantly
rom day 7 to day 10 (Figure 4F). Importantly, the pro-
ortion of CD4+ cells that are T reg shows a significant
nverse correlation with parasite growth rates; in sub-
ects with a higher percentage of CD4+ T reg, parasite
ensities of 1000 parasites/ml (or the highest recorded
arasite count if less than 1000/ml) were reached sig-
ificantly earlier than in subjects with lower percent-
ges of T reg (r = −0.748, p = 0.013) (Figure 4G).
. falciparum-Induced T Reg Suppress Antigen-
pecific Immune Responses
o confirm the suppressive effect of putative T reg,
. falciparum schizont extract (PfSE)-induced IFN-γ
roduction and lymphocyte proliferation was assessed
n PBMC with or without magnetic bead depletion of
D25hi cells (Figures 5A and 5B); PBMC were collected
rom 11 malaria-infected individuals on days 0, 7, 10,
nd 35 pi and cultured with antigen for 72 hr. Prolifera-
ion and IFN-γ production in response to culture me-
Regulatory T Cells in Human Malaria
291Figure 3. Increased Number of TGF-β+
CD14+ Cells among PBMC of Subjects with
Raised Plasma TGF-β Concentrations
(A–C) PBMC collected on days 4 and 7 post-
infection from 3 subjects with and 3 subjects
without a peak of bioactive TGF-β on day 7
were stained for CD4/CD8/CD14 and intra-
cellular TGF-β. TGF-β-positive cells (con-
tinuous line) were gated (horizontal bar) by
comparison with cells stained with isotype
control (dotted line) (A) and examined for ex-
pression of CD4, CD8 (B), or CD14 (C).
(D) The proportion of cells producing TGF-β
and the contribution of CD4+, CD8+, and
CD14+ cells producing TGF-β is shown for
each individual.dium or uninfected RBC (uRBC) were consistently low,
with no significant difference between depleted and un-
depleted samples at any time point. By contrast, stimu-
lation with PHA resulted in a strong proliferative re-
sponse and induced high levels of IFN-γ at all time
points, and these responses did not differ significantly
between depleted and undepleted cells.
Figure 5 shows the effects of depletion of CD25hi
cells on the proliferative (Figure 5C) and IFN-γ (Figure
5D) responses of PBMC, expressed as the ratio of stim-
ulation indices (SI; cpm value or IFN-γ concentration for
PfSE-stimulated cells/uRBC-stimulated cells) of de-
pleted versus undepleted cells.
On days 0 and 7, CD25hi depletion did not affect
either proliferation or IFN-γ production, which is consis-
tent with there being no change in T reg numbers or
FOXP3 expression (Figure 4) and no effect of TGF-β on
parasite densities at these time points (Figure 2). How-
ever, for PBMC collected on day 10, by which time
FOXP3 expression and the proportion of CD4+CD25hi
CD69− T cells were significantly increased, depletion of
CD25hi cells resulted in a 2.34-fold increase in prolifera-
tion, which was significantly higher than at day 7 (p =
0.002) (Figure 5C). A similar, albeit not significant, trend
was observed for IFN-γ production (Figure 5D). There
was a trend for the increase in proliferation in CD25+-
depleted cultures to be greater for the TGF-β-positive
donors than for the TGF-β-negative donors and for en-
hancement of both proliferation and IFN-γ production
to be greater in donors with a higher percentage of cells
with a T reg phenotype (data not shown). Importantly,
the increase in proliferation after CD25hi depletion of
cells collected on day 10 correlates significantly with
the level of FOXP3 measured on day 10 (correlation co-
efficient: 0.762, p = 0.01), supporting the view thatFOXP3 is a reliable marker for functional T reg. Taken
together, these data indicate that P. falciparum-induced
CD4+CD25hi cells are able to regulate the response of
P. falciparum-responsive effector cells.
Discussion
This study of immune responses during the prepatent
phase of human P. falciparum malaria infection has re-
vealed a burst of systemic TGF-β activity in 50% of in-
fected subjects within 12 hr of the first detection of
blood-stage infection. This early burst of TGF-β activity
is strongly associated with suppression of proinflam-
matory cytokine responses, faster parasite growth, and
induction of a population of CD4+ T cells with the hall-
marks of T reg. Therefore, this study suggests that not
only may T reg facilitate establishment of infection, but
an individual’s propensity for T reg induction or activa-
tion may be a key component of susceptibility to infec-
tious disease. These data thus provide a firm founda-
tion for future studies of the role of TGF-β and T reg in
malaria-endemic populations.
The marked increase in plasma levels of bioactive
TGF-β (compared with the much less significant in-
crease in latent TGF-β) indicates that P. falciparum may
directly activate latent TGF-β to its bioactive form in vivo,
in a manner analogous to our previous in vitro observa-
tions in which products of P. falciparum-schizont-
infected erythrocytes activate latent TGF-β in a two-step
process involving parasite-derived metalloproteinases
and a thrombospondin-like molecule (Omer et al., 2003a).
The reason for upregulation of TGF-β in only some sub-
jects is unclear but, given that all subjects were in-
fected with equivalent numbers of genetically identical
parasites, may reflect host genetic variation.
Immunity
292Figure 4. Upregulation of FOXP3 and T Reg Cells during Blood-Stage Infection
(A) Changes in FOXP3/HPRT ratio over time were determined in samples from 10 nonvaccinated, sporozite-challenged volunteers.
(B) Fold increase of bioactive TGF-β (time of first detection of P. falciparum DNA versus baseline) correlates with fold increase in FOXP3 (day
7 versus day 10).
(C–E) T reg were identified as live cells that coexpressed CD4 and CD3 (R6) (C) and were simultaneously CD69neg (R3) (D) and CD25hi (R4)
(E). (Only cells gated as R6 are shown in [D] and [E].)
(F) The proportions of CD25hi/CD69neg/CD3+/CD4+ lymphocytes (R4) were determined for 10 malaria-infected subjects in comparison to three
malaria naive unchallenged controls.
(G) The proportion of T reg at day 10 correlated negatively with parasite growth rate (days from infection to parasite density of 1000/ml).
Although a negative linear correlation is significant (r = −0.748, p = 0.013), a better fit is obtained with a first-order inverse polynomial
relationship (r = 0.83 p = 0.0028).The correlation between early TGF-β activation, de-
layed and diminished proinflammatory cytokine re-
sponses, and enhanced parasite growth is reminiscent
of infection of C57BL/6 mice with the lethal 17XL strain
of P. yoelii, which also induces high levels of TGF-β
within 24 hr of blood-stage infection; in this model, the
causal relationship between TGF-β induction, T reg ac-
tivity, and clinical outcome is proven since neutraliza-
tion of TGF-β and IL-10 signaling (Omer et al., 2003b)
or in vivo depletion of CD25hi cells during the early
phase of infection (Hisaeda et al., 2004) restored the
IFN-γ response and allowed parasitaemia to be con-
trolled.
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tIn humans, the kinetics of TGF-β activation (peak
lasma levels at day 7.5 pi with CD14+ monocytes be-
ng the major source), induction of FOXP3 and detec-
ion of functional T reg (after day 7 and before day 10
i), and IFN-γ upregulation or suppression (day 10.5 pi),
ogether with recent reports that TGF-β may induce T
eg cells (Chen et al., 2003; Fantini et al., 2004; Park
t al., 2004; Schramm et al., 2004; Zheng et al., 2004),
uggests the following sequence of events. In the pres-
nce of malaria antigens, TGF-β may induce FOXP3 ex-
ression in naive peripheral CD4+ T cells that subse-
uently differentiate into T reg; these cells then suppress
he IFN-γ response, leading to less constrained parasite
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293Figure 5. Depletion of CD25hi Cells Enhances
PBMC Proliferative and IFN-γ Responses to
Malaria Antigens
(A and B) CD25hi cells were depleted from
PBMC from 11 donors collected on days 0,
7, 10, and 35 after sporozoite infection (plot
[A] shows cells prior to depletion, [B] shows
cells after depletion) or PBMC were mock
depleted (not shown).
(C and D) The increase in proliferation (C)
and IFN-γ production (D) in response to
PfSE, observed in CD25hi-depleted PBMC is
shown, expressed as the ratio of stimulation
indices (cpm value or IFN-γ concentration for
PFSE-stimulated cells divided by cpm value
or IFN- γ concentration for uRBC-stimulated
cells) in depleted versus undepleted PBMC.growth. It is possible that TGF-β directly exerts sus-
tained inhibition of IFN-γ-producing T cells, but this is
unlikely given the short half-life of this cytokine. How-
ever, inhibition of the early burst of NK cell-derived
IFN-γ by TGF-β (as recently described in mice; Laouar
et al., 2005) is a plausible explanation for our findings.
A causal relationship between these events is sup-
ported by the very tight correlations observed between
each step of the proposed pathway: upregulation of
TGF-β is strongly correlated with upregulation of FOXP3
and with the increased proportion of fully functional
CD4+CD25hi T reg, while the proportion of T reg is
strongly correlated with parasite growth rates.
Our observation that TGF-β appears to emanate from
monocyte-macrophages is consistent with recent studies
in mice indicating important non-T cell sources for
TGF-β (Fahlen et al., 2005; Marie et al., 2005). Further-
more, it is consistent with recent studies in murine ma-
laria showing that antigen-presenting cell populations
can modulate the T cell response during malaria infec-
tions via release of modulatory cytokines, including IL-
10 as well as TGF-β (Perry et al., 2005; K.N. Couper,
D.G. Blount, J.B.d.S., and E.M.R., unpublished data),
and with reports that malaria-infected red blood cells
can induce human dendritic cells to secrete anti-infla-
matory cytokines (Urban et al., 1999).
Overall, our data demonstrate that numbers of regu-
latory T cells increase upon infection with P. falciparum
and, in parallel, parasite growth is facilitated by sup-
pression of proinflammatory cytokine responses. Irre-
spective of whether this represents de novo differentia-
tion of T reg or expansion of a preexisting population,
our data support the view that T reg can be induced in
the periphery via a mechanism that involves TGF-β and
FOXP3. These cells are readily detected in peripheral
blood, but we cannot rule out that cells are also se-questered in the liver, spleen, or other organs where
parasitized erythrocytes accumulate. While initially of
benefit to the parasite, facilitating the establishment of
blood-stage infection, P. falciparum-induced T reg may
contribute to the control of inflammatory responses
later in infection, thereby reducing immunopathology
and preventing the onset of severe malaria (de Souza
and Riley, 2002). In support of this possibility, immuno-
epidemiological studies indicate that low levels of TGF-β
are associated with acute (Wenisch et al., 1995) and
severe (Chaiyaroj et al., 2004; Perkins et al., 2000) ma-
laria and that an imbalance between systemic levels of
proinflammatory cytokines and TGF-β increases the
risk of clinical malaria (Dodoo et al., 2002). Thus, in
cases of mild clinical malaria, once parasitaemia is un-
der control, T reg may produce—or induce production
of—TGF-β (Jonuleit et al., 2002) and IL-10 (Dieckmann
et al., 2002; Jonuleit et al., 2002), which shut down the
inflammatory response; individuals in whom this T reg
response is defective may then be at risk of pro-
gressing to severe disease. Furthermore, by inhibiting
ongoing Th-1-mediated effector mechanisms, T reg ac-
tivity may favor asymptomatic parasite persistence, fa-
cilitating both long-term immunological memory (pre-
munition) and parasite transmission to the next host.
These observations are important, as our study of the
role of T reg in a natural infection of humans describes
the sequence of events and thus implies causal associ-
ations. In human hepatitis C virus (HCV) infection, dem-
onstration of T reg activity in chronically infected but
not recovered individuals (Cabrera et al., 2004; Sugi-
moto et al., 2003) has been interpreted as evidence that
T reg activity can favor pathogen chronicity at the ex-
pense of the host (who will eventually develop severe
disease), but the cross-sectional nature of these studies
precludes firm conclusions regarding cause and effect.
Immunity
294Studies of other chronic human infections (onchocerci-
asis [Satoguina et al., 2002], human immunodeficiency
virus [Aandahl et al., 2004; Kinter et al., 2004], and Heli-
cobacter pylori [Lundgren et al., 2003]) suffer from the
same limitations.
In conclusion, the use of a well-established and safe
parasite challenge model has allowed demonstration of
a direct correlation between activation of regulatory T
cells and enhanced blood-stage parasite growth, pro-
viding evidence that FOXP3-expressing regulatory T
cells have infection-modifying activity in vivo in humans.
Experimental Procedures
Subject Recruitment, Vaccination, and Malaria Infection
26 malaria-naive subjects that were exposed to the bites of five
P. falciparum (strain 3D7) sporozoite-infected A. stephensi mosqui-
toes in the context of two phase IIa vaccine trials (McConkey et al.,
2003) were studied. 14 subjects had received experimental pre-
erythrocytic malaria vaccines (FP9-MVA prime boost vaccines en-
coding ME-TRAP [Bejon et al., 2005], CS, or both); 12 were unvac-
cinated controls. All subjects were healthy, with a median age of
22 years (range: 20–38 years). Venous blood was collected on day
0, day 4, and twice daily from day 6.5 until the first microscopic
detection of parasitaemia, at which time subjects were cured with
artemether/lumefantrine. A final blood sample was collected on
day 35. The vaccination regimes employed did not induce any de-
tectable protective immunity, and there was no significant differ-
ence in the day of patency or subsequent parasite densities be-
tween vaccinated and control subjects (M.W., unpublished data,
data not shown). Serum and platelet-depleted plasma (van Waarde
et al., 1997) was stored from each sample. PBMC were cryopre-
served from control subjects on days 0, 4, 7, 10, and 35. Ethical
approval was obtained from the Oxfordshire Research Ethics Com-
mittee, UK, and the Human Subjects Protection Committee, Seat-
tle, WA.
Multiplex Analysis of Serum Cytokine Concentration
IL-6, IL-12p70, and IFN-γ were assayed in serum for each subject
and each time point using multiplex luminescent beads (Linco Re-
search Inc., MO). Data were analyzed using StatLIA software (Bren-
dan Scientific). The detection limit was 3.2 pg/ml for each of the
cytokines tested; values below this threshold were set to 3.2 pg/ml.
TGF- ELISA
Platelet-depleted plasma samples were assayed for TGF-β using
commercial reagents (human TGF-β-1DuoSet, R&D Systems, Ab-
ingdon, UK). Spontaneously bioactive TGF-β was measured di-
rectly; total TGF-β (spontaneously bioactive plus latent) was mea-
sured in samples after acid activation as described by the
manufacturer. Latent TGF-β concentration was calculated by sub-
traction of spontaneously bioactive TGF-β from total TGF-β. The
detection limit was 15 pg/ml; extrapolated values below this cut-
off were set to 15 pg/ml.
IFN- ELISA
Serum samples from supernatants of the proliferation assay were
assayed for IFN-γ as described previously (Dodoo et al., 2002).
P. falciparum Detection by PCR and Microscopy
P. falciparum DNA was assayed by quantitative real-time PCR (An-
drews et al., 2005), and at least 200 high-power fields of a thick film
were examined by two expert slide readers for malaria parasites
(McConkey et al., 2003).
P. falciparum Schizont Antigens
Freeze-thawed lysates of P. falciparum-schizont-infected red blood
cells (PfSE) were prepared as described (Rhee et al., 2001) from
P. falciparum clone 3D7, maintained in continuous culture, and rou-
tinely screened for mycoplasma by PCR (Bio Whittaker, Woking-
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pam, UK). Similar preparations of uninfected erythrocytes (uRBC)
ere used as controls.
OXP3 Assay by RT-PCR
T-PCR for FOXP3 was performed as described elsewhere (H.A.
letcher et al., submitted). RNA was prepared from frozen PBMCs
Rneasy, Qiagen, Crawley, UK), stabilized with RNase inhibitor
RNAsin, Promega/Invitrogen, Paisley, UK), and reverse transcribed
o cDNA using oligo-dT-primers (MWG Biotech, Milton Keynes, UK)
nd Omniscript reverse transcriptase (Omniscript kit, Qiagen).
uantitative RT-PCR (ABI PRISM, Applied Biosystems, Warrington,
K) was carried out using the SYBR Green (Qiagen) method with
he following primers: HPRT (F 5#-TATGGACAGGACTGAACGTC-3#
nd R 5#-CTACAATGTGATGGCCTCCC-3#), and FOXP3 (F 5#-CAC
TACAGGCACTCCTCCAGG-3# and R 5#-CCACCGTTGAGAGCTG
TGCAT-3#).
ell Culture
BMCs were separated from heparinized blood by density centrifu-
ation (Lymphoprep; Nycomed, Uppsala, Sweden) and cryopre-
erved (5–10 × 106 PBMC/ml) in heat-inactivated fetal calf serum
FCS) containing 10% DMSO (both Sigma, Poole, UK). For assays,
ells were thawed, washed, and resuspended in RPMI 1640 with
0% human serum, 100 IU/ml penicillin, 0.1 mg/ml streptomycin
all Sigma), and 2 mM L-glutamine (GIBCO/Invitrogen, Paisley, UK);
ll samples from a single donor were analyzed concurrently. PBMC
ere split in two aliquots (each of 1.3 × 106 live cells in 1 ml); and
D25hi (but not CD25low) cells were selectively removed using mag-
etic beads (Dynal Biotech, Bromborough, UK) at a bead to PBMC
atio of 7:1. Control cells were mock-depleted using sheep-anti-
ouse-Ig-coated beads (Dynal Biotech). Depleted and control cells
ere aliquoted (100 l/well) into triplicate wells of 96× U-well plates
ogether with 5 × 104 pRBC or uRBC, 5 g/ml PHA, or medium
lone and incubated for 5 days at 37°C in 5% CO2, and cell prolifer-
tion was determined by [3H]-thymidine (Amersham, UK) incorpo-
ation. Culture supernatant was saved for IFN-γ ELISA after 3.5
ays.
low Cytometry
hawed PBMC were directly stained using fluorochrome-labeled
onoclonal mouse anti-human antibodies and appropriate isotype
ontrols (anti-CD25 FITC [IgG1], anti-CD4 PerCP [IgG1 k], anti-CD8
ITC [IgG1], anti-CD69 PE [IgG1] [all BD Immunocytometry Sys-
ems, Oxford, UK], anti-CD-14 APC [IgG2a], and anti-CD3 APC
IgG2a] [both BD Pharmingen, Oxford, UK]), fixed (Cellfix, BD Bio-
ciences), permeabilized, and stained for intracellular TGF-β (Arta-
anis-Tsakonas and Riley, 2002) using anti-TGF-β1 PE (IgG1, IQ
roducts, Groningen, NL) or the appropriate isotype control. Cells
ere analyzed by flow cytometry (FACSCalibur, BD Biosciences)
ollecting a total of 100,000 events in a live gate; data were ana-
yzed using CellQuest (BD Biosciences).
tatistical Analysis
uantitative data were assessed for normal distribution and log-
ransformed where appropriate. Correlation coefficients, Student’s
test (paired or unpaired) comparing arithmetic or geometric
eans, and Willcoxon rank sum or signed rank test performed on
onnormally distributed data were calculated using SPSS for Win-
ows Version 11.0 (Lead Tools). 95% confidence intervals were cal-
ulated using CIA 2.1 (Trevor Bryant, Southampton). Linear regres-
ion analysis was performed to assess the difference of parasite
rowth between subgroups with and without early TGF-β response
sing Stata 8.0 (StataCorp, Austin, TX).
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